Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: An in vitro study

被引:156
作者
Cheng, Yiyun [1 ]
Qu, Haiou
Ma, Minglu
Xu, Zhenhua
Xu, Peng
Fang, Yujie
Xu, Tongwen
机构
[1] Univ Sci & Technol China, Lab Funct Membranes, Dept Chem, Hefei 230026, Anhui, Peoples R China
[2] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China
[3] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China
关键词
polyamidoamine dendrimers; PAMAM; drug carrier; antibacterial drugs; quinolones; nadifloxacin; prulifloxacin; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; STARBURST DENDRIMERS; SOLUBILITY; PRULIFLOXACIN; FLUOROQUINOLONES; CIPROFLOXACIN; INFECTIONS; CHEMISTRY; SHAPE;
D O I
10.1016/j.ejmech.2006.12.035
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Quinolones, an expanding class of clinically established potent antibiotics, is not freely soluble in water which prevents the design of liquid dosage forms and restricts their use in topical applications. In the present study we investigated the potential of polyamidoamine (PAMAM) dendrimers as drug carriers of quinolones (nadifloxacin and prulifloxacin) by aqueous solubility and antibacterial activity studies. Results showed that the aqueous solubility of nadifloxacin and prulifloxacin was significantly increased by PAMAM dendrimers. Microbiology studies showed that nadifloxacin and prulifloxacin still exhibit their strong antimicrobial activities in the presence of dendrimers. These studies indicated that PAMAM dendrimers might be considered as biocompatible carriers of quinolones under suitable conditions. (c) 2007 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1032 / 1038
页数:7
相关论文
共 44 条
[1]   Formulation of a neutral solution of ciprofloxacin upon complexation with aluminum [J].
Allemandi, DA ;
Alovero, F ;
Manzo, RH .
FARMACO, 1999, 54 (11-12) :758-760
[2]  
[Anonymous], 2001, DENDRIMERS OTHER DEN
[3]  
[Anonymous], DRUG DISCOVERY TODAY
[4]   A prodrug approach toward the development of water soluble fluoroquinolones and structure-activity relationships of quinoline-3-carboxylic acids [J].
Baker, WR ;
Cai, SP ;
Dimitroff, M ;
Fang, LM ;
Huh, KK ;
Ryckman, DR ;
Shang, X ;
Shawar, RM ;
Therrien, JH .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (19) :4693-4709
[5]  
BHARATHI D, 2005, INT J PHARM, V304, P193
[6]  
Bharathi D., 2004, INT J PHARMACEUT, V284, P133
[7]   Screening of anti-bacterial activity of medicinal plants from Belize (Central America) [J].
Camporese, A ;
Balick, MJ ;
Arvigo, R ;
Esposito, RG ;
Morsellino, N ;
De Simone, F ;
Tubaro, A .
JOURNAL OF ETHNOPHARMACOLOGY, 2003, 87 (01) :103-107
[8]   Prulifloxacin: A new fluoroquinolone for the treatment of acute exacerbation of chronic bronchitis [J].
Cazzola, M ;
Salvatori, E ;
Dionisio, P ;
Allegra, L .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2006, 19 :30-37
[9]   Solubilization of non-steroidal anti-inflammatory drugs in the presence of tween series surfactants [J].
Cheng, Yiyun ;
Yang, Jiepin .
PHYSICS AND CHEMISTRY OF LIQUIDS, 2006, 44 (03) :249-256
[10]   Polyamidoamine dendrimers used as solubility enhancers of ketoprofen [J].
Cheng, YY ;
Xu, TW ;
Fu, RQ .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2005, 40 (12) :1390-1393